Genotype Directed Antiplatelet Therapy, Is The Time Right

Genotype Directed Antiplatelet Therapy, Is the Time Right?

TAILOR-PCI and the role of genotype-guided antiplatelet therapy

CYP2C19-Guided Antiplatelet Therapy After PCI

Circulation, an American Heart Association Journal

GM10: Clopidogrel - Larisa Cavallari

National Human Genome Research Institute

CYP2C19 genotyping to guide antiplatelet therapy

THE CARDIOLOGIST

PRODIGY & Dual Antiplatelet Therapy Trials (2 of 2)

ECGtoCardiology

Precision Medicine Using Genotype to Inform Prescribing

Personalized Antiplatelet Therapy

Emory Cardiology

The role of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia

VJHemOnc – Video Journal of Hematology & HemOnc

Clopidogrel use after stroke: CYP2C19 Genotype Testing

National Institute for Health and Care Excellence (NICE)

Antiplatelet Therapy in Coronary Artery Disease

Optimization of Anti-platelet Therapy in ACS

Interventional Academy

Antiplatelet Therapy in High Bleeding Risk Patients Following PCI, November 6, 2020

Cardiology University of Washington

CCD Guideline - Antiplatelet Therapy

American Heart Association

Management of acute coronary syndrome and antiplatelet use

Genotype 1 Hepatitis C is Common with Increasingly Effective Treatment

The Changing Face of Dual Anti-Platelet Therapy: Implications for the Internist

ClevelandClinicCME

Assessing Sex Differences in Patients With Stroke or TIA When Treated With Dual Antiplatelet Therapy

Eccles Health Sciences Library Digital Publishing

DAPT in 2023: How low can you go?

Antiplatelet therapy after coronary stenting

MedLecturesMadeEasy